Periodontal tissue engineering by FGF-2:Its present status and future outlook
Murakami, S.
Clinical Calcium 26(7): 1064-1070
2016
ISSN/ISBN: 0917-5857 PMID: 27346319 Document Number: 689601
Periodontitis remains highly prevalent all over the world and can lead to loss of the affected teeth. Thus, establishing a brand-new treatment that enables the regeneration and rebuilding of periodontal tissue destroyed by periodontitis represents a task of tremendous importance. Our pre-clinical studies and clinical trials suggested that efficacy is expected from basic fibroblast growth factor(FGF-2)in stimulating regeneration of periodontal tissue. Development of the osteoconductive carrier for FGF-2 drug will further extend the indications in the field of dental medicine.